Ropivacaine Though Laterosternal Catheters After Cardiac Surgery
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This is a prospective double-blinded and randomised study involving patients undergoing
cardiac surgery with median sternotomy, the effects on postoperative analgesia of a 48-hr
continuous infusion of ropivacaine 2 mg.mL-1, at the rate of 4 mL.hr-1 through two catheters
inserted at the lateral edges of the sternum will be studied, versus a control group in which
normal saline will be infused in the same conditions.